Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma

Daisaku Yamada, Shogo Kobayashi, Hidenori Takahashi, Yoshifumi Iwagami, Hirofumi Akita, Kei Asukai, Junzo Shimizu, Terumasa Yamada, Masahiro Tanemura, Shigekazu Yokoyama, Masanori Tsujie, Tadafumi Asaoka, Yutaka Takeda, Osakuni Morimoto, Akira Tomokuni, Yuichiro Doki, Hidetoshi Eguchi

Open source

DOI: 10.1038/s41598-025-23185-7
Published: 2025-11-12
Container: Scientific Reports
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-23185-7,
  title = {Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma},
  author = {Daisaku Yamada and Shogo Kobayashi and Hidenori Takahashi and Yoshifumi Iwagami and Hirofumi Akita and Kei Asukai and Junzo Shimizu and Terumasa Yamada and Masahiro Tanemura and Shigekazu Yokoyama and Masanori Tsujie and Tadafumi Asaoka and Yutaka Takeda and Osakuni Morimoto and Akira Tomokuni and Yuichiro Doki and Hidetoshi Eguchi},
  year = {2025},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-025-23185-7},
  url = {https://doi.org/10.1038/s41598-025-23185-7}
}

RIS

TY  - JOUR
TI  - Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma
AU  - Daisaku Yamada
AU  - Shogo Kobayashi
AU  - Hidenori Takahashi
AU  - Yoshifumi Iwagami
AU  - Hirofumi Akita
AU  - Kei Asukai
AU  - Junzo Shimizu
AU  - Terumasa Yamada
AU  - Masahiro Tanemura
AU  - Shigekazu Yokoyama
AU  - Masanori Tsujie
AU  - Tadafumi Asaoka
AU  - Yutaka Takeda
AU  - Osakuni Morimoto
AU  - Akira Tomokuni
AU  - Yuichiro Doki
AU  - Hidetoshi Eguchi
PY  - 2025
JO  - Scientific Reports
DO  - 10.1038/s41598-025-23185-7
UR  - https://doi.org/10.1038/s41598-025-23185-7
ER  -

APA

Yamada, D., Kobayashi, S., Takahashi, H., Iwagami, Y., Akita, H., Asukai, K., Shimizu, J., Yamada, T., Tanemura, M., Yokoyama, S., Tsujie, M., Asaoka, T., Takeda, Y., Morimoto, O., Tomokuni, A., Doki, Y., & Eguchi, H. (2025). Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma. Scientific Reports. https://doi.org/10.1038/s41598-025-23185-7

Source records

crossref · retrieved 2026-09-26T08:51:42.342Z